down arrow

Sai Life

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE570L01029
  • NSEID: SAILIFE
  • BSEID: 544306
INR
870.00
3.2 (0.37%)
BSENSE

Dec 05

BSE+NSE Vol: 18.04 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Sai Life Sciences Ltd stock-summary
stock-summary
Sai Life Sciences Ltd
Small Cap
Pharmaceuticals & Biotechnology
Sai Life Sciences Limited was originally incorporated as `Sai Dru Syn Laboratories Limited' as a Public Limited Company, dated January 25, 1999, issued by the Registrar of Companies, Andhra Pradesh at Hyderabad. The Company received the Certificate of Commencement of Business from Registrar of Companies, Andhra Pradesh on February 17, 1999. Subsequently, the Company name was changed from `Sai Dru Syn Laboratories Limited' to `Sai Life Sciences Limited' dated December 16, 2003.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR None Cr
Number of Shares
None Cr
Face Value
INR None
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 26 Schemes (26.16%)

FIIs

Held by 139 FIIs (22.49%)

Promoter with highest holding

Mytreyi Kanumuri Partner Of Marigold Partners (partnership Firm) (10.57%)

Highest Public shareholder

Invesco India Midcap Fund (7.15%)

Individual Investors Holdings

7.9%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Cost of Material Consumed
445.519
0%
 
100
Cost of Material Consumed
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
537 Cr
(Quarterly Results - Sep 2025)
Net Profit:
84 Cr
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 18,290 Cr (Small Cap)

stock-summary
P/E

105.00

stock-summary
Industry P/E

34

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.03

stock-summary
Return on Equity

7.53%

stock-summary
Price to Book

7.93

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."